- Forums
- ASX - By Stock
- MSB
- Ann: Novartis and Mesoblast Remestemcel-L Collaboration
Ann: Novartis and Mesoblast Remestemcel-L Collaboration, page-5
-
-
- There are more pages in this discussion • 807 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.50 |
Change
-0.015(0.99%) |
Mkt cap ! $1.701B |
Open | High | Low | Value | Volume |
$1.50 | $1.53 | $1.48 | $3.485M | 2.322M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
20 | 66028 | $1.50 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.51 | 11484 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
18 | 62224 | 1.495 |
17 | 85880 | 1.490 |
13 | 142222 | 1.485 |
8 | 62744 | 1.480 |
3 | 8721 | 1.475 |
Price($) | Vol. | No. |
---|---|---|
1.505 | 13888 | 9 |
1.510 | 43820 | 7 |
1.515 | 56740 | 8 |
1.520 | 131637 | 9 |
1.525 | 36456 | 6 |
Last trade - 13.41pm 13/11/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online